Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer
Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comp...
Saved in:
Published in | Advanced materials (Weinheim) Vol. 37; no. 4; p. e2406662 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
01.01.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor‐targeting photothermal therapy (PTT) to simultaneously tackle multiple immune‐suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT‐Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT‐mediated ICD effect and the transactivation of the cGAS‐STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT‐Mn Lipo NPs‐mediated PTT promoted M1 polarization of tumor‐associated macrophages, augmented T‐cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT‐Mn Lipo NPs‐based PTT with a checkpoint blockade therapy (anti‐PD‐1) can elicit long‐term immune memory besides tumor eradication. Collectively, this nano‐system can systemically activate antitumor immunity through STING activation and potentially establish long‐term memory against tumor recurrence. |
---|---|
AbstractList | Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor‐targeting photothermal therapy (PTT) to simultaneously tackle multiple immune‐suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT‐Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT‐mediated ICD effect and the transactivation of the cGAS‐STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT‐Mn Lipo NPs‐mediated PTT promoted M1 polarization of tumor‐associated macrophages, augmented T‐cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT‐Mn Lipo NPs‐based PTT with a checkpoint blockade therapy (anti‐PD‐1) can elicit long‐term immune memory besides tumor eradication. Collectively, this nano‐system can systemically activate antitumor immunity through STING activation and potentially establish long‐term memory against tumor recurrence. Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor-targeting photothermal therapy (PTT) to simultaneously tackle multiple immune-suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT-Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT-mediated ICD effect and the transactivation of the cGAS-STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT-Mn Lipo NPs-mediated PTT promoted M1 polarization of tumor-associated macrophages, augmented T-cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT-Mn Lipo NPs-based PTT with a checkpoint blockade therapy (anti-PD-1) can elicit long-term immune memory besides tumor eradication. Collectively, this nano-system can systemically activate antitumor immunity through STING activation and potentially establish long-term memory against tumor recurrence.Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator of interferon genes (STING) pathway has been thought a promising strategy to enhance immunotherapy efficacy. In this study, we adopted a comprehensive strategy that integrates innate immune responses with tumor-targeting photothermal therapy (PTT) to simultaneously tackle multiple immune-suppressive mechanisms in breast cancer. This semiconducting polymeric nanoagonists (DPTT-Mn Lipo NPs) mediated PTT can effectively initiate tumor cell apoptosis and induce ICD, thereby reprogramming the immunosuppressive TME and activating STING. We confirmed the modulation of the TME through the PTT-mediated ICD effect and the transactivation of the cGAS-STING pathway in immune cells of the TME due to the released dsDNA via ICD, such as macrophages and DCs. Indeed, DPTT-Mn Lipo NPs-mediated PTT promoted M1 polarization of tumor-associated macrophages, augmented T-cell infiltration, facilitated dendritic cell (DC) maturation, and regulated type I interferon factor secretion, leading to efficient tumor suppression. Most importantly, the combination of DPTT-Mn Lipo NPs-based PTT with a checkpoint blockade therapy (anti-PD-1) can elicit long-term immune memory besides tumor eradication. Collectively, this nano-system can systemically activate antitumor immunity through STING activation and potentially establish long-term memory against tumor recurrence. |
Author | Xu, Xiaolong Chen, Chunbo Li, Zhijie Long, Ying Wong, Yin Kwan Bai, Yunmeng Yuan, Haitao Wang, Peili Xiao, Wei Yi, Letai Fu, Chunjin Wang, Xiaoxian Ma, Jingbo Wei, Jinxi Qiu, Chong Huang, Wei Peng, Xin Wang, Jigang |
Author_xml | – sequence: 1 givenname: Haitao surname: Yuan fullname: Yuan, Haitao organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China – sequence: 2 givenname: Chong surname: Qiu fullname: Qiu, Chong organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China – sequence: 3 givenname: Xiaoxian surname: Wang fullname: Wang, Xiaoxian organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 4 givenname: Peili surname: Wang fullname: Wang, Peili organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, National Clinical Research Center for Chinese Medicine Cardiology Xiyuan Hospital China Academy of Chinese Medical Sciences Beijing 100700 P. R. China – sequence: 5 givenname: Letai surname: Yi fullname: Yi, Letai organization: Inner Mongolia Medical University Hohhot Inner Mongolia 010000 P. R. China – sequence: 6 givenname: Xin surname: Peng fullname: Peng, Xin organization: Ningbo Municipal Hospital of TCM Affiliated Hospital of Zhejiang Chinese Medical University Ningbo 315010 P. R. China – sequence: 7 givenname: Xiaolong surname: Xu fullname: Xu, Xiaolong organization: Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China – sequence: 8 givenname: Wei surname: Huang fullname: Huang, Wei organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 9 givenname: Yunmeng surname: Bai fullname: Bai, Yunmeng organization: Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China – sequence: 10 givenname: Jinxi surname: Wei fullname: Wei, Jinxi organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 11 givenname: Jingbo surname: Ma fullname: Ma, Jingbo organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 12 givenname: Yin Kwan surname: Wong fullname: Wong, Yin Kwan organization: Department of Physiology Yong Loo Lin School of Medicine National University of Singapore Singapore 117600 Singapore – sequence: 13 givenname: Chunjin surname: Fu fullname: Fu, Chunjin organization: State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China – sequence: 14 givenname: Wei surname: Xiao fullname: Xiao, Wei organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China – sequence: 15 givenname: Chunbo surname: Chen fullname: Chen, Chunbo organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Department of Critical Care Medicine Shenzhen People's Hospital The Second Clinical Medical College of Jinan University The First Affiliated Hospital of Southern University of Science and Technology Shenzhen 518020 P. R. China – sequence: 16 givenname: Ying surname: Long fullname: Long, Ying organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 17 givenname: Zhijie surname: Li fullname: Li, Zhijie organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China – sequence: 18 givenname: Jigang orcidid: 0000-0002-0575-0105 surname: Wang fullname: Wang, Jigang organization: Department of Hyperbaric Oxygen Medicine Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatric Shenzhen People's Hospital The First Affiliated Hospital Southern University of Science and Technology Shenzhen Guangdong 518020 P. R. China, Center for Drug Research and Development Guangdong Provincial Key Laboratory of Advanced Drug Delivery System Guangdong Pharmaceutical University Guangzhou 510006 P. R. China, State Key Laboratory for Quality Ensurance and Sustainable Use of Dao‐di Herbs Artemisinin Research Center and Institute of Chinese Materia Medica China Academy of Chinese Medical Sciences Beijing 100700 P. R. China, State Key Laboratory of Antiviral Drugs School of Pharmacy Henan University Kaifeng 475004 P. R. China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39629527$$D View this record in MEDLINE/PubMed |
BookMark | eNpd0c1uEzEQB3ALFdG0cOWILHHhssEfu_b6GKIQKoVSkXBeee1JcLVrF9sLyo1H4AF4Op4ERy09cLJm_PPImv8FOvPBA0IvKZlTQthbbUc9Z4TVRAjBnqAZbRitaqKaMzQjijeVEnV7ji5SuiWEKEHEM3TOlWCqYXKGfq_8wXmA6PwBb2F0Jng7mXwqb8JwHMuNwdfaB30I3qWcSjuDz05nwGa92P75-Wu7u7pe4xudv_7QR7wor7_r7ILH2lu8GpxxGW9CmbiDOOKPMIZY2EE7nzL-DGaKEbwB7Dx-F0GX5lKXOj5HT_d6SPDi4bxEX96vdssP1ebT-mq52FSGyTZXXApr97yxLe2FUQ1oomTdS8laKpsGFJe2l4wDqD2vubV9r1upFDAwPeOaX6I393PvYvg2Qcrd6JKBYdAewpQ6TstCmaoFLfT1f_Q2TNGX3xUliGSkEaqoVw9q6kew3V10o47H7t_eC5jfAxNDShH2j4SS7hRsdwq2ewyW_wVCDJgO |
Cites_doi | 10.1016/j.apsb.2019.01.018 10.1002/anie.202315031 10.1016/j.apsb.2022.02.021 10.1021/jacs.2c09608 10.1021/acsnano.3c01404 10.1002/adma.202307115 10.1002/smll.202006970 10.1038/s41565-022-01225-x 10.1038/s41467-023-36878-2 10.1016/j.cej.2024.150364 10.1002/adfm.202313384 10.1002/advs.202309583 10.1021/jacs.2c12772 10.1038/s43018-022-00447-1 10.1021/jacs.2c03266 10.1038/s43018-020-0028-4 10.1002/advs.202401905 10.1021/jacs.3c11314 10.1016/j.chom.2017.06.013 10.1038/ncomms14392 10.1186/s12943-020-01247-w 10.1002/smll.202202161 10.1038/s41467-023-37825-x 10.1002/anie.202318539 10.1038/s43018-022-00468-w 10.1002/anie.201904751 10.1002/anie.202101924 10.1038/s41467-023-42883-2 10.1016/j.apsb.2021.11.005 10.1021/am508026s 10.1038/s41467-021-22572-8 10.1016/j.apsb.2023.08.015 10.1038/s41467-018-04703-w 10.1186/s40425-019-0811-x 10.1002/adfm.202307241 10.1021/acs.accounts.3c00394 |
ContentType | Journal Article |
Copyright | 2024 Wiley‐VCH GmbH. 2025 Wiley‐VCH GmbH |
Copyright_xml | – notice: 2024 Wiley‐VCH GmbH. – notice: 2025 Wiley‐VCH GmbH |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SR 8BQ 8FD JG9 7X8 |
DOI | 10.1002/adma.202406662 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Engineered Materials Abstracts METADEX Technology Research Database Materials Research Database MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Engineered Materials Abstracts Technology Research Database METADEX MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic Materials Research Database |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Engineering |
EISSN | 1521-4095 |
ExternalDocumentID | 39629527 10_1002_adma_202406662 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Shenzhen Science and Technology Innovation Committee grantid: RCYX20221008092950121 – fundername: Scientific and technological innovation project of China Academy of Chinese Medical Sciences grantid: CI2023D008 – fundername: GuangDong Basic and Applied Basic Research Foundation grantid: 2021A1515012164 – fundername: International Science and Technology Cooperation for Shenzhen Technology Innovation Plan grantid: GJHZ20200731095411034 – fundername: National Natural Science Foundation of China grantid: 82070517 – fundername: CACMS Innovation Fund grantid: CI2023E002 – fundername: Shenzhen Fund for Guangdong Provincial High- level Clinical Key Specialties grantid: SZGSP001 – fundername: Central Public Welfare Research Institutes grantid: ZZ14-YQ-055 – fundername: National Natural Science Foundation of China grantid: 22407049 – fundername: Shenzhen Science and Technology Innovation Program grantid: JCYJ20210324114202008 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 23M 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 6P2 6TJ 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 8WZ 930 A03 A6W AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAYOK AAYXX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADMLS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AETEA AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGYGG AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CITATION CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM EBS EJD F00 F01 F04 F5P FEDTE FOJGT G-S G.N GNP GODZA H.T H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6K MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NDZJH NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI Q.N Q11 QB0 QRW R.K RIWAO RJQFR RNS ROL RX1 RYL SAMSI SUPJJ TN5 UB1 UPT V2E W8V W99 WBKPD WFSAM WIB WIH WIK WJL WOHZO WQJ WTY WXSBR WYISQ XG1 XPP XV2 YR2 ZY4 ZZTAW ~02 ~IA ~WT AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7SR 8BQ 8FD JG9 7X8 |
ID | FETCH-LOGICAL-c278t-376ddf35d81b6c95ea0974b77281755e937db723ee9f343ddbba8799e2ecb23a3 |
ISSN | 0935-9648 1521-4095 |
IngestDate | Fri Jul 11 03:34:42 EDT 2025 Fri Jul 25 22:20:02 EDT 2025 Mon Jul 21 06:04:16 EDT 2025 Tue Jul 01 00:55:00 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | cGAS‐STING semiconducting polymeric nanoagonists elicit long term memory immunogenic cell death photothermal therapy |
Language | English |
License | 2024 Wiley‐VCH GmbH. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c278t-376ddf35d81b6c95ea0974b77281755e937db723ee9f343ddbba8799e2ecb23a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0575-0105 |
PMID | 39629527 |
PQID | 3160720569 |
PQPubID | 2045203 |
ParticipantIDs | proquest_miscellaneous_3140929461 proquest_journals_3160720569 pubmed_primary_39629527 crossref_primary_10_1002_adma_202406662 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-01-01 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Weinheim |
PublicationTitle | Advanced materials (Weinheim) |
PublicationTitleAlternate | Adv Mater |
PublicationYear | 2025 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | e_1_2_8_28_1 e_1_2_8_29_1 e_1_2_8_24_1 e_1_2_8_25_1 e_1_2_8_26_1 e_1_2_8_27_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_21_1 e_1_2_8_22_1 e_1_2_8_23_1 e_1_2_8_1_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
References_xml | – ident: e_1_2_8_17_1 doi: 10.1016/j.apsb.2019.01.018 – ident: e_1_2_8_22_1 doi: 10.1002/anie.202315031 – ident: e_1_2_8_15_1 doi: 10.1016/j.apsb.2022.02.021 – ident: e_1_2_8_34_1 doi: 10.1021/jacs.2c09608 – ident: e_1_2_8_28_1 doi: 10.1021/acsnano.3c01404 – ident: e_1_2_8_16_1 doi: 10.1002/adma.202307115 – ident: e_1_2_8_9_1 doi: 10.1002/smll.202006970 – ident: e_1_2_8_32_1 doi: 10.1038/s41565-022-01225-x – ident: e_1_2_8_2_1 doi: 10.1038/s41467-023-36878-2 – ident: e_1_2_8_8_1 doi: 10.1016/j.cej.2024.150364 – ident: e_1_2_8_27_1 doi: 10.1002/adfm.202313384 – ident: e_1_2_8_4_1 doi: 10.1002/advs.202309583 – ident: e_1_2_8_13_1 doi: 10.1021/jacs.2c12772 – ident: e_1_2_8_35_1 doi: 10.1038/s43018-022-00447-1 – ident: e_1_2_8_29_1 doi: 10.1021/jacs.2c03266 – ident: e_1_2_8_7_1 doi: 10.1038/s43018-020-0028-4 – ident: e_1_2_8_26_1 doi: 10.1002/advs.202401905 – ident: e_1_2_8_12_1 doi: 10.1021/jacs.3c11314 – ident: e_1_2_8_31_1 doi: 10.1016/j.chom.2017.06.013 – ident: e_1_2_8_18_1 doi: 10.1038/ncomms14392 – ident: e_1_2_8_25_1 doi: 10.1186/s12943-020-01247-w – ident: e_1_2_8_21_1 doi: 10.1002/smll.202202161 – ident: e_1_2_8_36_1 doi: 10.1038/s41467-023-37825-x – ident: e_1_2_8_11_1 doi: 10.1002/anie.202318539 – ident: e_1_2_8_6_1 doi: 10.1038/s43018-022-00468-w – ident: e_1_2_8_23_1 doi: 10.1002/anie.201904751 – ident: e_1_2_8_10_1 doi: 10.1002/anie.202101924 – ident: e_1_2_8_3_1 doi: 10.1038/s41467-023-42883-2 – ident: e_1_2_8_14_1 doi: 10.1016/j.apsb.2021.11.005 – ident: e_1_2_8_20_1 doi: 10.1021/am508026s – ident: e_1_2_8_19_1 doi: 10.1038/s41467-021-22572-8 – ident: e_1_2_8_30_1 doi: 10.1016/j.apsb.2023.08.015 – ident: e_1_2_8_1_1 doi: 10.1038/s41467-018-04703-w – ident: e_1_2_8_33_1 doi: 10.1186/s40425-019-0811-x – ident: e_1_2_8_5_1 doi: 10.1002/adfm.202307241 – ident: e_1_2_8_24_1 doi: 10.1021/acs.accounts.3c00394 |
SSID | ssj0009606 |
Score | 2.4839525 |
Snippet | Triple‐negative breast cancer has an immunologically “cold” microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator... Triple-negative breast cancer has an immunologically "cold" microenvironment, which leads to resistance to current immunotherapy. The activation of stimulator... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database |
StartPage | e2406662 |
SubjectTerms | Animals Breast cancer Breast Neoplasms - immunology Breast Neoplasms - pathology Breast Neoplasms - therapy Cell Line, Tumor Female Humans Immune system Immunotherapy Interferon Low temperature resistance Macrophages Membrane Proteins - metabolism Mice Nanoparticles - chemistry Nucleotidyltransferases - metabolism Polymers - chemistry Semiconductors Signal Transduction - drug effects Stimulators Tumor Microenvironment - drug effects |
Title | Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast Cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39629527 https://www.proquest.com/docview/3160720569 https://www.proquest.com/docview/3140929461 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LjtMwFLXKsIEF4k1hQEZCYhF1aB3n4WUZBioEqGI6oqwi23GHSCVBM4lgWPEJfAB_wR_xJdwbO4-iIg1sosZ1Hso9ts-9uTmXkEdjHXIdYVo51krlsfRHiuloFGplWGTCMU_rLN834eyIv1wGy8HgZy9rqSrVnv669buS_7EqtIFd8SvZf7Bse1JogN9gX9iChWF7Lhv3xARh0H8Eo-Yo34q782J9ZtPkYf4s5HGBCrmn0FxiehAQTE-_mB62qQ6HC4xazYEOfpZn3lQ3Rc_qdwsH60xnpfcKyxItYCb3XmN6LnQ7lhmwS6SetcqTrgVInmKae-ntI5xO-tx32qQbAEm2Twfp7TuT5R8M1nRuQxLvKxuVncmslEUbms0qmx9QuMW2fg1gp6plJosvPaA37XOTrbN-YIMFvcCGi1D6wUiEVohzz7j5maHLa-tyNhO4VY1xQOVb1wWrMyvTWmoKSUzo1oANAe4_FsY2XdFKO7MEj0_a4y-Qiwx8Eyyb8extp1mGLmEt8OjuvlEKHbMnm9ffZEJ_cW9qmrO4Sq44_4ROLdiukYHJr5PLPaDdID96e3QTdrSFHe3Djnawowi7X9--14CjDnC0AxwFwFELOIqAowg4agFHHeBoBzia5dQCjlrA3SRHzw8W-7ORK_Ix0iyKS1zg0nTlByn4T6EWgZFjcHEVPNgYmG1ggD6nKmK-MWLlcz9NlZJxJIRhRivmS_8W2cmL3NwhFJzzVKbAuFZ8whUXsUE6a6D_RPGJCIbkcfPAk09WyyXZbtoh2W3skbjxfpr4qMXIwGEQQ_Kw_RtmY3zFJnNTVNgHwMkEDydDctvasb2UL0ImAhbdPfdt3COXuoGxS3bKk8rcBw5cqgc15n4DR2qztA |
linkProvider | Wiley-Blackwell |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Engineering+Semiconducting+Polymeric+Nanoagonists+Potentiate+cGAS%E2%80%90STING+Pathway+Activation+and+Elicit+Long+Term+Memory+Against+Recurrence+in+Breast+Cancer&rft.jtitle=Advanced+materials+%28Weinheim%29&rft.au=Yuan%2C+Haitao&rft.au=Qiu%2C+Chong&rft.au=Wang%2C+Xiaoxian&rft.au=Wang%2C+Peili&rft.date=2025-01-01&rft.issn=0935-9648&rft.eissn=1521-4095&rft.volume=37&rft.issue=4&rft_id=info:doi/10.1002%2Fadma.202406662&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_adma_202406662 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0935-9648&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0935-9648&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0935-9648&client=summon |